Your browser doesn't support javascript.
loading
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of melanoma, version 3.0.
Pavlick, Anna C; Ariyan, Charlotte E; Buchbinder, Elizabeth I; Davar, Diwakar; Gibney, Geoffrey T; Hamid, Omid; Hieken, Tina J; Izar, Benjamin; Johnson, Douglas B; Kulkarni, Rajan P; Luke, Jason J; Mitchell, Tara C; Mooradian, Meghan J; Rubin, Krista M; Salama, April Ks; Shirai, Keisuke; Taube, Janis M; Tawbi, Hussein A; Tolley, J Keith; Valdueza, Caressa; Weiss, Sarah A; Wong, Michael K; Sullivan, Ryan J.
Afiliação
  • Pavlick AC; Weill Cornell Medicine, New York, New York, USA acp9008@med.cornell.edu.
  • Ariyan CE; Department of Surgery Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Buchbinder EI; Melanoma Disease Center, Dana Farber Cancer Institute, Boston, Massachusetts, USA.
  • Davar D; Hillman Cancer Center, University of Pittsburg Medical Center, Pittsburgh, Pennsylvania, USA.
  • Gibney GT; Lombardi Comprehensive Cancer Center, MedStar Georgetown University Hospital, Washington, District of Columbia, USA.
  • Hamid O; The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles, California, USA.
  • Hieken TJ; Department of Surgery and Comprehensive Cancer Center, Mayo Clinic, Rochester, Minnesota, USA.
  • Izar B; Department of Medicine, Division of Hematology/Oncology, Columbia University Medical Center, New York, New York, USA.
  • Johnson DB; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Kulkarni RP; Departments of Dermatology, Oncological Sciences, Biomedical Engineering, and Center for Cancer Early Detection Advanced Research, Knight Cancer Institute, OHSU, Portland, Oregon, USA.
  • Luke JJ; Operative Care Division, VA Portland Health Care System (VAPORHCS), Portland, Oregon, USA.
  • Mitchell TC; Hillman Cancer Center, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
  • Mooradian MJ; Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
  • Rubin KM; Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Salama AK; Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Shirai K; Department of Medicine, Division of Medical Oncology, Duke University, Durham, Carolina, USA.
  • Taube JM; Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.
  • Tawbi HA; Department of Dermatology, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Tolley JK; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Valdueza C; Patient Advocate, Melanoma Research Alliance, Washington, DC, USA.
  • Weiss SA; Cutaneous Oncology Program, Weill Cornell Medicine, New York, New York, USA.
  • Wong MK; Department of Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA.
  • Sullivan RJ; Patient Advocate, Melanoma Research Alliance, Washington, DC, USA.
J Immunother Cancer ; 11(10)2023 10.
Article em En | MEDLINE | ID: mdl-37852736
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Melanoma Idioma: En Ano de publicação: 2023 Tipo de documento: Article